IXC 1.41% 7.0¢ invex therapeutics ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17

  1. 1,036 Posts.
    lightbulb Created with Sketch. 79
    I guess its just amazing that when the Invex announcement came regarding the "Granted European Orphan Drug Designation for TBI", the share price spiked from 38 cents to 60 cents.

    Now the company is worth less than the cash in the company. Cash burn should also slow down going forward. Maybe no possibility of other opportunities arising for this company.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $5.261M
Open High Low Value Volume
7.1¢ 7.1¢ 7.0¢ $4.214K 59.36K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 52542 1
View Market Depth
Last trade - 15.32pm 20/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.